# Repair Signals, Minus the Rosy Filter > Peachy Peptides — Recovery & Tissue Repair Research Peptides — An exacting guide to Recovery & Tissue Repair research peptides, comparing GHK-Cu, BPC-157, and GLOW through skin-texture and barrier-repair evidence. **RECOVERY & TISSUE REPAIR / EVIDENCE DESK** A critical reading of GHK-Cu, BPC-157, and the GLOW research blend—where skin-texture signals exist, where animal models dominate, and where the claim simply has not been tested. ### [GHK-Cu](/ghk-cu) ![GHK-Cu research illustration](images/ghk-cu.webp) The only member here with a meaningful skin-facing literature, although small topical studies and difficult skin penetration keep the conclusion modest. ### [BPC-157](/bpc-157) ![BPC-157 research illustration](images/bpc-157.webp) A synthetic gastric peptide with striking repair findings in animals and almost no basis for confident claims about human skin or tissue outcomes. ### [GLOW (research blend)](/glow) ![GLOW research blend illustration](images/glow.webp) A non-standardized combination of GHK-Cu, BPC-157, and TB-500 whose appeal is mechanistic; the blend itself has no controlled clinical trial. ## The short version The attractive idea is simple: some peptides may help cells rebuild the material around them, move into damaged areas, or form new blood vessels. The evidence is not simple. **GHK-Cu** has the most relevant skin record on this desk, including small human topical studies and laboratory work on collagen and other parts of the skin matrix. **BPC-157** has a large reputation but is supported mainly by animal and cell studies. **GLOW** combines GHK-Cu, BPC-157, and TB-500, yet the combined product has not been tested in a controlled clinical trial [13]. A smoother-looking surface reported in a topical study is not interchangeable with tendon repair in a rat, and neither proves that an injectable blend improves human skin. Peachy Peptides keeps appearance outcomes attached to the study that reported them, labels community accounts as anecdote, and treats a proposed biological pathway as a hypothesis rather than a result. The least exciting conclusion is often the accurate one. ## Three entries, three evidentiary problems [**GHK-Cu**](/ghk-cu) is a copper-binding tripeptide studied in skin biology. Reviews describe signals involving collagen, elastin, glycosaminoglycans, decorin, and matrix-remodeling enzymes [4][14]. Limited topical human work reports improvements in laxity, density, and fine lines [4]. Native GHK is also poor at crossing the outer skin barrier, so formulation and delivery are central to whether a laboratory mechanism can matter on actual skin [1][5]. [**BPC-157**](/bpc-157), the lead compound here, is better described as an unresolved research program than a demonstrated human repair treatment. Rat studies report gastric-ulcer and Achilles-tendon healing signals [10][11], while endothelial experiments link it to new-vessel signaling [9]. A human pilot involved only two adults and did not test efficacy [6]; a later review found only three human pilots in total [7]. [**GLOW**](/glow) is a variable research blend, usually GHK-Cu, BPC-157, and TB-500. The theory joins matrix remodeling, blood-vessel signaling, and cell migration. No controlled study establishes that the components remain stable together, work better together, or produce a human appearance outcome. A review naming all three constituents emphasizes favorable animal findings, scarce rigorous human safety data, and the hazards of unregulated availability [13]. ## What are research peptides? Peptides are short chains of amino acids, the building blocks used to make larger proteins. Their size and sequence allow them to interact with receptors, bind metals, or participate in cell signaling. The label **research peptide** describes an experimental context, not a certificate of effectiveness, purity, or safety. It can include a peptide used as a cosmetic ingredient in one form, an unapproved molecule studied mostly in animals, or a commercial blend assembled from several compounds. Route, formulation, study model, and outcome all matter. Topical Copper Tripeptide-1 has a cosmetic record, but systemic GHK-Cu does not inherit that evidence. BPC-157 is not an approved medicine, and its human evidence remains too thin to establish therapeutic benefit [7]. GLOW is a supplier-defined combination rather than a standardized drug, and conclusions from one ingredient cannot validate the mixture [13]. A cell experiment can identify a mechanism. An animal experiment can test biology in a living system. A controlled human trial can begin to estimate benefit and harm in people. Those are successive levels of evidence, not synonyms. ## How this desk handles appearance claims Skin texture is easy to market and difficult to measure cleanly. Hydration can make a surface look temporarily smoother. Lighting can make a photograph persuasive. A biological marker can move without producing a visible change. This digest therefore asks what material was tested, whether the work used cells, animals, isolated human skin, or living participants, and whether the outcome was a molecular marker, an instrument reading, or a subjective impression. GHK-Cu earns the strongest place in this frame because human topical observations exist, but the studies are small and much of the broader literature comes from a concentrated group of investigators [1][4]. BPC-157 earns attention for repair mechanisms, not a claim of proven skin improvement. GLOW earns scrutiny because combining plausible mechanisms is not the same as testing a blend. The [comparison matrix](/compare) keeps those distinctions visible; the [reference ledger](/references) keeps every numbered claim traceable. --- Peachy Peptides is an independent audit of skin-and-repair literature—neither a treatment desk nor a place where a plausible pathway gets promoted to medical advice.